2-50346870-GCGCCGCCGCCGCCGCCGCCGC-GCGCCGCCGCCGCCGCCGC
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP3BP6_Very_Strong
The ENST00000342183.9(NRXN1):c.77_79delGCG(p.Gly26del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000722 in 1,354,980 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G26G) has been classified as Likely benign.
Frequency
Consequence
ENST00000342183.9 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- chromosome 2p16.3 deletion syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Pitt-Hopkins-like syndrome 2Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autismInheritance: AD Classification: MODERATE Submitted by: G2P
- schizophreniaInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000998 AC: 15AN: 150364Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000907 AC: 68AN: 74950 AF XY: 0.000769 show subpopulations
GnomAD4 exome AF: 0.000799 AC: 963AN: 1204616Hom.: 0 AF XY: 0.000890 AC XY: 524AN XY: 588858 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0000998 AC: 15AN: 150364Hom.: 0 Cov.: 32 AF XY: 0.0000682 AC XY: 5AN XY: 73352 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at